AMG Oncology - Naperville — Naperville, Illinois

AMG Oncology - Naperville is a clinical research site located in Naperville, Illinois, United States 60540.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

AMG Oncology - Naperville has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation.

Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AMG Oncology - Naperville?

AMG Oncology - Naperville has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AMG Oncology - Naperville conducted?

AMG Oncology - Naperville has 6 clinical trials on record, with 2 currently active. Their work covers ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation.

Is AMG Oncology - Naperville accredited by Crixeo Health?

AMG Oncology - Naperville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AMG Oncology - Naperville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.